| pubmed-article:10506726 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C0002871 | lld:lifeskim |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C0014822 | lld:lifeskim |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C0005841 | lld:lifeskim |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:10506726 | lifeskim:mentions | umls-concept:C1879316 | lld:lifeskim |
| pubmed-article:10506726 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:10506726 | pubmed:dateCreated | 1999-10-18 | lld:pubmed |
| pubmed-article:10506726 | pubmed:abstractText | Anemia has been reported to develop during preoperative chemotherapy with paclitaxel and carboplatin. The use of recombinant human erythropoietin (EPO) has been shown to reduce anemia and subsequent packed red blood cell transfusions. The current study is a report of a Phase III, prospective, randomized trial with or without EPO that confirms the original observations of less anemia and fewer transfusions in those patients randomized to receive EPO concurrently with paclitaxel and carboplatin. | lld:pubmed |
| pubmed-article:10506726 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10506726 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10506726 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10506726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10506726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10506726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10506726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10506726 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10506726 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:10506726 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:10506726 | pubmed:author | pubmed-author:HiltonJ GJG | lld:pubmed |
| pubmed-article:10506726 | pubmed:author | pubmed-author:HarrisonB RBR | lld:pubmed |
| pubmed-article:10506726 | pubmed:author | pubmed-author:BondE DED | lld:pubmed |
| pubmed-article:10506726 | pubmed:author | pubmed-author:DunphyF RFR | lld:pubmed |
| pubmed-article:10506726 | pubmed:author | pubmed-author:RodriguezJ... | lld:pubmed |
| pubmed-article:10506726 | pubmed:author | pubmed-author:DunleavyT LTL | lld:pubmed |
| pubmed-article:10506726 | pubmed:copyrightInfo | Copyright 1999 American Cancer Society. | lld:pubmed |
| pubmed-article:10506726 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10506726 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:10506726 | pubmed:volume | 86 | lld:pubmed |
| pubmed-article:10506726 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10506726 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10506726 | pubmed:pagination | 1362-7 | lld:pubmed |
| pubmed-article:10506726 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:meshHeading | pubmed-meshheading:10506726... | lld:pubmed |
| pubmed-article:10506726 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10506726 | pubmed:articleTitle | Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy. | lld:pubmed |
| pubmed-article:10506726 | pubmed:affiliation | Division of Hematology and Oncology, Department of Internal Medicine, Saint Louis University Health Sciences Center, St. Louis, Missouri 63110-0250, USA. | lld:pubmed |
| pubmed-article:10506726 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10506726 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10506726 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10506726 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10506726 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10506726 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10506726 | lld:pubmed |
